The Mexico Bariatric Surgery Market size was valued at USD XX Billion in 2022 and is expected to surpass USD XX Billion by 2031, expanding at a CAGR of 4.8% during the forecast period, 2023 – 2031. The growth of the market is attributed to increasing burden of chronic diseases such as heart diseases and diabetes.
Bariatric surgery means the obesity surgery entails a number of operations that are carried out on fat persons. It's a hormonal procedure in which the technique's restriction and malabsorption cause a shift in gut hormones. About 90% of diabetic people are suffering from overweight. The rising prevalence of chronic illnesses such as diabetes & heart disease are major drivers of the market.
In long-term studies of this disease treatment leads to considerable long-term weight loss, improvements in cardiovascular risk factors, diabetes recovery, and mortality reduction of 40% to 23%. This treatment is used when the patients failed to lose weight by using several other treatments. Various devices are used for the bariatric surgery treatment such as closure devices, assisting devices, implantable devices, and others. This is major treatment procedures for treating obesity. The rise of the bariatric surgery devices market may be attributable to new product releases, medical device advancements, and increased demand for obesity control operations. The amount of bariatric surgical treatments has increased dramatically since the introduction of laparoscopic surgery.
Market Trends, Drivers, Restraints, and Opportunities
-
Number of obese patients is increasing thus; it is projected to drive the Mexico bariatric surgery market during forecast period.
-
Increased number of diabetes cases is likely to increase obesity, which is estimated to propel the demand of bariatric surgery market in Mexico.
-
Bariatric surgery is majorly used for treating obesity and it is last option for those patients failed to lose weight by others treatment, this is estimated to fuel the market.
-
High cost of the bariatric surgery is projected to hamper the market growth.
-
Improper closing of the incisions post-surgery by closure devices and others can cause a hernia, which restrains the market growth.
-
Rising organized crime, corruption, and inefficiency in government, is projected to hamper the market growth.
-
Bariatric surgery is one of the safest and most reliable ways to treat obesity-related morbidity, and closure devices are an important part of the surgical technique, fast and more effective production of this devices are anticipated to create lucrative opportunities for the market players.
Scope of the Report
The report on the Mexico bariatric surgery market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Mexico Bariatric Surgery Market - Industry Analysis, Growth, Trends, and Forecasts
|
|
Base Year
|
2022
|
|
Historic Data
|
2016-2021
|
|
Forecast Period
|
2023-2031
|
|
Segmentation
|
Device Type (Assisting Devices, Implantable Devices, and Others)
|
|
Country Scope
|
Mexico
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Boston Scientific Corporation.; Apollo Endosurgery Inc.; Johnsons & Johnson.; Medtronic Plc.; Olympus Corporation
|
Market Segment Insights
The closure device segment is expected to grow at a rapid pace
Based on device types, the Mexico bariatric surgery market is divided into assisting devices, implantable devices, closure devices, and others. The closure device segment is expected to grow at a rapid pace during the forecast owning to highly used closure devices in bariatric surgery due to considerable cases of obesity. Closure device in bariatric procedures is used to reconnect tissue as well as close incisions produced using trocars.
According to the organization for economic cooperation and development, Mexico is the second most obese country in the world, with a 39% rise is anticipated during forecast period. Bariatric surgery is viewed as one of the safest and most reliable ways to treat obesity-related morbidity, and closure devices are an important part of the surgical technique. A hernia might develop if the wounds are not properly closed after surgery.
Mexico is anticipated to constitute a key market share
According to the international diabetes federation, in 2020, about 12,805,200 cases of diabetes were found. By World Health Organization, about 90% of diabetic people suffer from overweight problems. As a result, increasing number of diabetes cases are predicted to increase obesity, which drives the demand for bariatric surgery in Mexico. Poor diets, excessive sugar consumption, and a lack of physical activity all contribute to obesity.
Segments
Device Type
- Assisting Devices
- Implantable Devices
- Others
Country
Key Players
Competitive Landscape
Key players competing in the Mexico bariatric surgery market include Boston Scientific Corporation.; Apollo Endosurgery Inc.; Johnsons & Johnson.; Medtronic Plc.; Olympus Corporation.; ReShape Lifescience Inc.; Aspire Bariatrics.; and the Cooper Companies. Some of the key players are constantly implementing several marketing strategies such as merge & acquisitions, capital investments, partnerships, and new product development for bariatric surgery diseases.
Request For Customization
Enquiry Before Buying
Speak With Analyst
